Alpha Teknova (TKNO) Change in Account Payables (2021 - 2026)
Alpha Teknova (TKNO) posted quarterly Change in Account Payables of $330000.0 for Q1 2026, down 55.41% year-over-year from $740000.0 in Q1 2025, and up 46.02% quarter-over-quarter from $226000.0 in Q4 2025.
Alpha Teknova (TKNO) Change in Account Payables (2021 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has reported Change in Account Payables for 6 consecutive years, with $330000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables fell 55.41% year-over-year to $330000.0; the TTM figure through Mar 2026 stood at $60000.0 (up 361.54% YoY), while the FY2025 annual figure was $470000.0, up 179.12% from the prior year.
- Change in Account Payables improved to $330000.0 in Q1 2026 per TKNO's latest filing, from $226000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.2 million in Q3 2022 and bottomed at -$976000.0 in Q2 2023.
- Historically, Change in Account Payables has averaged $294.12 across 5 years, with a median of -$41000.0 in 2024.
- Annual changes were most pronounced in 2023 — Change in Account Payables tumbled 262.87% — and 2025, when it surged 456.39%.
- Alpha Teknova's Change in Account Payables stood at -$397000.0 in 2022, then soared by 144.08% to $175000.0 in 2023, then tumbled by 193.71% to -$164000.0 in 2024, then surged by 237.8% to $226000.0 in 2025, then soared by 46.02% to $330000.0 in 2026.
- Business Quant data shows TKNO's Change in Account Payables at $330000.0 in Q1 2026, $226000.0 in Q4 2025, and -$136000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alpha Teknova | 396.90 Mn | 379.46 Mn | 4.89 Mn | -172,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -172,000.00 |
| Jun 30, 2026 | -172,000.00 |
| Mar 31, 2026 | 330,000.00 |
| Mar 31, 2026 | 330,000.00 |
| Dec 31, 2025 | 226,000.00 |
| Dec 31, 2025 | 226,000.00 |
| Sep 30, 2025 | -136,000.00 |
| Sep 30, 2025 | -136,000.00 |
| Jun 30, 2025 | -360,000.00 |
| Jun 30, 2025 | -360,000.00 |
| Mar 31, 2025 | 740,000.00 |
| Mar 31, 2025 | 740,000.00 |
| Dec 31, 2024 | -164,000.00 |
| Dec 31, 2024 | -164,000.00 |
| Sep 30, 2024 | -41,000.00 |
| Sep 30, 2024 | -41,000.00 |
| Jun 30, 2024 | -522,000.00 |
| Jun 30, 2024 | -522,000.00 |
| Mar 31, 2024 | 133,000.00 |
| Mar 31, 2024 | 133,000.00 |